The vaccine used to protect humans against the anthrax disease, called Anthrax Vaccine Adsorbed (AVA), was licensed in 1970. Congress directed the Department of Defense to support an independent examination of AVA. This work reports the study's conclusion that the vaccine is acceptably safe and effective in protecting humans against anthrax.